Nutra Pharma Balance Sheet (2010-2026)

Reported Financials

Nutra Pharma Quarterly Balance Sheet

Periods 65 quarters

Latest Jun 2026

Nutra Pharma reported total assets of $0.62M and total liabilities of $21.83M for the quarter ended Jun 2026, down 27.5% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.04M	0.09M	0.01M	0.01M							0.25M	0.25M	0.25M	0.04M	0.01M	0.08M	0.25M	0.01M	0.25M	0.25M
Short-term InvestmentsInvestments (Current)										0.04M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M
Cash & Current Investments	0.04M	0.09M	0.01M	0.01M						0.04M	0.27M	0.27M	0.27M	0.05M	0.03M	0.10M	0.27M	0.03M	0.27M	0.27M
Receivables - NetNet Receivables	0.04M	0.05M	0.05M	0.05M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.04M	0.03M	0.03M	0.03M	0.03M
Receivables - OtherOther Receivables	0.44M		0.01M	0.09M	0.00M	0.00M	0.00M	0.14M	0.04M	0.00M	0.01M	0.01M	-0.01M	0.03M	0.10M	0.13M	0.15M	0.03M	0.13M	0.31M
Receivables	0.48M	0.05M	0.05M	0.13M	0.02M	0.02M	0.02M	0.16M	0.06M	0.03M	0.03M	0.03M	0.02M	0.05M	0.12M	0.16M	0.17M	0.06M	0.16M	0.33M
Raw Materials
Finished Goods
Inventory	0.03M	0.03M	0.06M	0.04M	0.05M	0.02M	0.03M	0.03M	0.03M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M
Prepaid Assets	0.19M	0.09M	0.09M	0.09M	0.12M	0.06M	0.06M	0.06M	0.07M	0.03M	0.03M	0.03M	0.03M	0.03M	0.15M	0.14M	0.11M	0.04M	0.06M	0.05M
Current Assets	0.57M	0.53M	0.50M	0.51M	0.46M	0.33M	0.33M	0.38M	0.36M	0.31M	0.32M	0.36M	0.31M	0.37M	0.55M	0.67M	0.55M	0.46M	0.50M	0.46M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.04M	0.04M	0.10M	0.09M	0.09M	0.08M	0.07M	0.07M	0.06M	0.02M	0.02M	0.01M	0.01M	0.01M	0.03M	0.03M	0.03M	0.03M	0.02M	0.02M
Long-Term Investments	0.10M	0.10M	0.10M	0.09M	0.09M	0.08M	0.08M	0.08M	0.08M	0.13M	0.12M	0.11M	0.11M	0.11M	0.11M	0.11M	0.10M	0.10M	0.09M	0.09M
Long-Term Deferred Tax
Other Non-Current Assets	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Non-Current Assets	0.26M	0.25M	0.28M	0.25M	0.23M	0.42M	0.40M	0.37M	0.35M	0.33M	0.30M	0.27M	0.25M	0.22M	0.22M	0.19M	0.16M	0.16M	0.12M	0.16M
Assets	0.84M	0.78M	0.78M	0.76M	0.69M	0.75M	0.72M	0.75M	0.71M	0.64M	0.62M	0.63M	0.56M	0.60M	0.78M	0.86M	0.71M	0.62M	0.62M	0.62M
Liabilities
Current Liabilities
Accounts Payables	0.61M	0.67M	0.74M	0.67M	0.71M	0.73M	0.81M	0.74M	0.75M	0.76M	0.83M	0.87M	0.84M	0.80M	0.81M	0.79M	0.77M	0.85M	0.84M	0.89M
Notes Payables	12.61M	10.54M	6.11M	5.39M	5.10M	0.63M	0.64M	0.64M	0.64M	0.66M	0.69M	0.70M	0.70M	0.71M	1.67M	0.92M	0.93M	0.96M	0.98M	2.04M
Payables	13.22M	11.21M	6.85M	6.05M	5.81M	1.36M	1.44M	1.38M	1.40M	1.42M	1.51M	1.57M	1.54M	1.51M	2.48M	1.72M	1.70M	1.81M	1.83M	2.93M
Accumulated Expenses	1.56M	1.05M	1.09M	1.13M	1.17M	1.68M	1.73M	1.77M	1.82M	1.90M	1.94M	2.01M	2.08M	2.10M	2.16M	2.12M	2.17M	2.19M	2.24M	2.31M
Other Accumulated Expenses	0.01M	0.20M	0.00M	0.00M	0.00M	0.11M	0.32M	0.47M	0.58M	0.66M	0.99M	1.11M	1.16M	1.24M	1.32M	1.38M	1.50M	1.59M	1.69M	1.77M
Short term Debt	7.78M	7.60M	7.02M	8.26M	7.86M	7.93M	8.04M	8.19M	8.21M	8.33M	8.25M	8.32M	8.29M	8.49M	8.92M	9.35M	9.54M	9.62M	0.11M
Current Leases	0.08M	0.08M	0.06M	0.04M	0.02M	0.07M	0.08M	0.08M	0.08M	0.08M	0.09M	0.09M	0.09M	0.09M	0.07M	0.05M	0.02M
Current Deferred Revenue				0.08M	0.11M	0.18M	0.28M	0.31M	0.36M	0.23M	0.23M	0.23M	0.24M
Total Current Liabilities	23.78M	21.14M	16.19M	16.74M	16.15M	12.70M	13.30M	13.65M	13.95M	14.17M	14.60M	15.00M	15.21M	15.27M	16.85M	16.55M	16.92M	17.31M	17.74M	21.70M
Non-Current Liabilities
Non-Current Debt	8.44M	1.14M	1.30M	1.34M	1.29M	1.33M	8.28M	8.40M	8.38M	8.47M	8.39M	8.46M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.13M
Convertible Debt	0.51M	0.37M	0.15M	0.05M	0.00M	0.00M	0.09M	0.09M	0.01M	0.01M								1.14M		2.42M
Operating Leases	0.10M	0.08M	0.06M	0.04M	0.02M	0.25M	0.23M	0.22M	0.20M	0.18M	0.16M	0.14M	0.11M	0.09M			0.02M
Other Non-Current Liabilities									0.05M	0.04M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M
Total Non-Current Liabilities									14.18M	14.37M	14.76M	15.14M	15.33M	15.35M	16.94M	16.64M	17.01M	17.40M	17.83M	21.78M
Total Liabilities	24.46M	21.66M	16.55M	16.95M	16.30M	13.13M	13.69M	14.00M	14.24M	14.41M	14.81M	15.19M	15.38M	15.41M	16.99M	16.69M	17.06M	17.45M	17.88M	21.83M
Shareholder's Equity
Total Debt	28.82M	19.27M	14.43M	14.98M	14.25M	9.89M	16.96M	17.22M	17.24M	17.46M	17.32M	17.48M	9.13M	9.34M	10.73M	10.41M	10.60M	10.72M	1.23M	2.17M
Common Equity	-23.62M	-20.88M	-15.77M	-16.20M	-15.61M	-12.38M	-12.97M	-13.25M	-13.53M	-13.77M	-14.19M	-14.56M	-14.82M	-14.81M	-16.21M	-15.83M	-16.35M	-16.83M	-17.26M	-21.21M
Liabilities and Shareholders Equity	0.84M	0.78M	0.78M	0.76M	0.69M	0.75M	0.72M	0.75M	0.71M	0.64M	0.62M	0.63M	0.56M	0.60M	0.78M	0.86M	0.71M	0.62M	0.62M	0.62M
Retained Earnings	-83.90M	-81.73M	-76.72M	-77.36M	-76.78M	-73.55M	-74.14M	-74.42M	-74.70M	-74.95M	-75.37M	-75.74M	-76.00M	-76.23M	-77.64M	-77.27M	-77.79M	-78.28M	-78.74M	-82.69M
Preferred Shares	0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Treasury Shares

Nutra Pharma NPHC Balance Sheet (2010-2026)

Nutra Pharma Quarterly Balance Sheet

Create an account

Sign In

Reset Password